Phase II Cancer Clinical Trials for Biomarker-Guided Treatments

Journal of Biopharmaceutical Statistics - United States
doi 10.1080/10543406.2017.1372777
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Phase I Cancer Clinical Trials

British Journal of Cancer
Cancer ResearchOncology
2007English

Phase II Cancer Trials: Out of Control?

Clinical Cancer Research
Cancer ResearchOncology
2007English

A Dose-Schedule Finding Design for Phase I-Ii Clinical Trials

Journal of the Royal Statistical Society. Series C: Applied Statistics
UncertaintyStatisticsProbability
2015English

Comparison of Error Rates in Single-Arm Versus Randomized Phase II Cancer Clinical Trials

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2010English

Predictors of Success of Phase II Pediatric Oncology Clinical Trials

Oncologist
Cancer ResearchMedicineOncology
2019English

ApoE Genotyping as a Progression-Rate Biomarker in Phase II Disease-Modification Trials for Alzheimer's Disease

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2009English

Phase 1 Clinical Trials in 83 Patients With Pancreatic Cancer

Cancer
Cancer ResearchOncology
2010English

Clinical Trials, End Points, and Statistics—Measuring and Comparing Cancer Treatments in Practice

JAMA Oncology
Cancer ResearchOncology
2018English

Pharmacogenomics in Early-Phase Oncology Clinical Trials: Is There a Sweet Spot in Phase II?

Clinical Cancer Research
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy